LFST Stock Analysis: Buy, Sell, or Hold?
LFST - LifeStance Health Group, Inc. Common Stock
$9.21
0.22 (2.51%)
▲
5d:
+8.29%
30d:
+19.86%
90d:
+43.83%
HOLD
MODERATE Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When LFST Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: LFST is 8.8% above its trading range ($8.46). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: LFST is 8.8% above its trading range ($8.46). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$17.33
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$10.76
14.4% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 22.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LFST is currently trading at $9.21, which is considered extended relative to its 30-day fair value range of $7.43 to $8.46. The stock's valuation (Forward PE: 23.5) is in line with its historical norms (22.7). At these levels, the market is pricing in 1.2% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, LFST is in a uptrend. The price is approaching resistance at $9.16. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: LFST has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $10.55 (+14.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, LFST is in a uptrend. The price is approaching resistance at $9.16. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: LFST has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $10.55 (+14.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$7.43 -
$8.46
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
55.7%
All Signals
- BEARISH: Price extended above range (+8.8% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($10.55)
- NEUTRAL: Market pricing in 1.2% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$7.43 -
$8.46
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$7.29
Resistance Level
$9.17
Current Trend
Uptrend
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
23.48
Wall Street Target
$10.55
(+14.6%)
Revenue Growth (YoY)
21.2%
Earnings Growth (YoY)
1927.5%
Profit Margin
1.6%
Valuation Premium vs History
+1.2% premium
PE vs Historical
23.5 vs 22.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.2%
(market-implied from PE analysis)
1-Year Target
$9.32
(+1%)
2-Year Target
$9.43
(+2%)
3-Year Target
$9.54
(+4%)
3-Yr Target (if PE normalizes)
(PE: 23→23)
PE COMPRESSION
$9.22
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 23.5, Growth: 25.8%)
$18.34
(+99%)
Base:
(SPY PE: 21.8, Growth: 25.8%)
$17.01
(+85%)
Bear:
(PE: 18.5, Growth: 25.8%)
$14.46
(+57%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (60x PE), but valuation improves significantly next year (23x PE) as earnings recover.
Forward PE: 59.88 | Forward EPS (Implied): $0.15
Bull Case
$11.12
(+21%)
Analyst growth 15.0%, PE expands to 62.9
Base Case
$9.21
(0%)
Market implied 0.0%, PE stable at 59.9
Bear Case
$7.04
(-24%)
Severe decline -15.0%, PE contracts to 53.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: June 23, 2026 6:29 AM ET
Data refreshes hourly during market hours. Next update: 7:29 AM
Data refreshes hourly during market hours. Next update: 7:29 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LFST showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Robert Bessler
SELL
5101 shares
2026-04-21
Darren M Black
SELL
4314939 shares
2026-03-02
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$244 | 57 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$504 | 60 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 53 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 54 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$133 | 58 HOLD |
